X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13324) 13324
Newsletter (104) 104
Book Chapter (32) 32
Book / eBook (8) 8
Newspaper Article (8) 8
Magazine Article (6) 6
Government Document (2) 2
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10721) 10721
female (7830) 7830
oncology (6982) 6982
cancer (5536) 5536
breast cancer (5340) 5340
middle aged (4808) 4808
breast neoplasms - pathology (3685) 3685
aged (3605) 3605
adult (3562) 3562
carcinoma (3194) 3194
prognosis (3080) 3080
breast neoplasms - drug therapy (2914) 2914
metastasis (2876) 2876
tumors (2851) 2851
animals (2535) 2535
chemotherapy (2449) 2449
expression (2386) 2386
research (2116) 2116
gene expression (1978) 1978
immunohistochemistry (1971) 1971
cell line, tumor (1940) 1940
male (1895) 1895
care and treatment (1876) 1876
carcinoma, ductal, breast - drug therapy (1796) 1796
proteins (1654) 1654
health aspects (1640) 1640
breast neoplasms - metabolism (1625) 1625
analysis (1624) 1624
medicine & public health (1606) 1606
surgery (1589) 1589
apoptosis (1588) 1588
survival (1526) 1526
mice (1468) 1468
cell biology (1443) 1443
aged, 80 and over (1439) 1439
pathology (1425) 1425
pancreatic cancer (1420) 1420
carcinoma, ductal, breast - pathology (1418) 1418
neoplasm staging (1401) 1401
medical prognosis (1395) 1395
cancer therapies (1389) 1389
development and progression (1357) 1357
genetic aspects (1353) 1353
breast-cancer (1317) 1317
treatment outcome (1280) 1280
breast neoplasms - genetics (1278) 1278
antineoplastic combined chemotherapy protocols - therapeutic use (1247) 1247
gene expression regulation, neoplastic (1241) 1241
therapy (1191) 1191
research article (1181) 1181
medicine (1171) 1171
breast neoplasms - surgery (1166) 1166
metastases (1089) 1089
kinases (1048) 1048
signal transduction (1033) 1033
cell proliferation (1005) 1005
chemotherapy, adjuvant (954) 954
diagnosis (941) 941
patients (926) 926
retrospective studies (911) 911
cancer research (893) 893
biomarkers, tumor - metabolism (892) 892
adenocarcinoma (891) 891
biochemistry & molecular biology (889) 889
biomarkers (886) 886
multidisciplinary sciences (864) 864
pancreatic neoplasms - pathology (860) 860
risk factors (856) 856
growth (849) 849
cells (841) 841
antineoplastic agents - therapeutic use (840) 840
lymphatic metastasis (822) 822
follow-up studies (807) 807
studies (806) 806
neoplasm invasiveness (804) 804
mutation (774) 774
breast neoplasms - mortality (764) 764
angiogenesis (761) 761
carcinoma, ductal, breast - metabolism (748) 748
medical research (744) 744
science (736) 736
survival rate (732) 732
stem cells (724) 724
disease-free survival (719) 719
review (716) 716
neoadjuvant therapy (713) 713
receptor, erbb-2 - metabolism (708) 708
carcinoma, ductal, breast - surgery (700) 700
cell cycle (685) 685
hepatocellular-carcinoma (681) 681
drug therapy (678) 678
cell growth (668) 668
disease progression (666) 666
gene-expression (663) 663
genes (661) 661
proliferation (660) 660
survival analysis (660) 660
women (659) 659
medicine, research & experimental (651) 651
oncology, experimental (646) 646
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13235) 13235
Japanese (140) 140
Chinese (81) 81
French (45) 45
German (44) 44
Spanish (37) 37
Italian (14) 14
Hungarian (8) 8
Russian (7) 7
Portuguese (6) 6
Danish (4) 4
Czech (3) 3
Norwegian (3) 3
Polish (3) 3
Romanian (2) 2
Bosnian (1) 1
Bulgarian (1) 1
Dutch (1) 1
Swedish (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of clinical oncology, ISSN 1527-7755, 2012, Volume 30, Issue 12, pp. 1268 - 1273
PURPOSE: The NSABP (National Surgical Adjuvant Breast and Bowel Project) B-24 study demonstrated significant benefit with adjuvant tamoxifen in patients with ductal carcinoma in situ (DCIS... 
LIGAND-BINDING ASSAY | PREDICTING RESPONSE | ONCOLOGY | PREVENTION | RECURRENCE | RANDOMIZED CONTROLLED-TRIAL | PROGESTERONE-RECEPTOR | OUTCOMES | RADIOTHERAPY | RADIATION-THERAPY | IMMUNOHISTOCHEMISTRY | Breast Neoplasms - surgery | Age Factors | Carcinoma in Situ - drug therapy | Follow-Up Studies | United States | Humans | Middle Aged | Receptors, Estrogen - analysis | Neoplasm Recurrence, Local - mortality | Tamoxifen - administration & dosage | Carcinoma, Intraductal, Noninfiltrating - mortality | Dose-Response Relationship, Drug | Antineoplastic Agents, Hormonal - adverse effects | Receptors, Progesterone - analysis | Carcinoma in Situ - surgery | Neoplasm Invasiveness - pathology | Adult | Female | Carcinoma, Intraductal, Noninfiltrating - surgery | Chemotherapy, Adjuvant | Mastectomy, Segmental - methods | Drug Administration Schedule | Neoplasm Recurrence, Local - prevention & control | Risk Assessment | Carcinoma in Situ - pathology | Antineoplastic Agents, Hormonal - administration & dosage | Kaplan-Meier Estimate | Carcinoma, Intraductal, Noninfiltrating - drug therapy | Breast Neoplasms - drug therapy | Disease-Free Survival | Receptors, Estrogen - drug effects | Carcinoma, Intraductal, Noninfiltrating - pathology | Breast Neoplasms - pathology | Receptors, Progesterone - drug effects | Survival Analysis | Breast Neoplasms - mortality | Aged | Tamoxifen - adverse effects | Neoplasm Staging | Carcinoma in Situ - mortality | Original Reports | Bc5
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 387, Issue 10021, pp. 849 - 856
Summary Background Ductal carcinoma in situ is currently managed with excision, radiotherapy, and adjuvant hormone therapy, usually tamoxifen... 
Internal Medicine | INTRADUCTAL BREAST-CANCER | MEDICINE, GENERAL & INTERNAL | SURGICAL ADJUVANT BREAST | RADIATION-THERAPY | B-17 | Breast Neoplasms - surgery | Triazoles - administration & dosage | Triazoles - adverse effects | Thrombosis - chemically induced | Age Factors | Humans | Middle Aged | Tamoxifen - administration & dosage | Nitriles - administration & dosage | Antineoplastic Agents, Hormonal - adverse effects | Aromatase Inhibitors - adverse effects | Carcinoma, Ductal, Breast - drug therapy | Mastectomy, Segmental | Antineoplastic Agents, Hormonal - therapeutic use | Postmenopause | Female | Embolism - chemically induced | Aromatase Inhibitors - therapeutic use | Triazoles - therapeutic use | Aromatase Inhibitors - administration & dosage | Carcinoma, Ductal, Breast - surgery | Double-Blind Method | Administration, Oral | Antineoplastic Agents, Hormonal - administration & dosage | Combined Modality Therapy | Breast Neoplasms - drug therapy | Breast Neoplasms - radiotherapy | Carcinoma, Ductal, Breast - radiotherapy | Tamoxifen - therapeutic use | Tamoxifen - adverse effects | Nitriles - adverse effects | Nitriles - therapeutic use | Lumpectomy | Medical colleges | Carcinoma | Radiation | Clinical trials | Postmenopausal women | Hormones | Tamoxifen | Radiotherapy | Biometry | Health maintenance organizations | Product development | Cancer | Chemotherapy | Womens health | Older people | Breast cancer | Radiation therapy | Cancer surgery
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2011, Volume 79, Issue 3, pp. 808 - 817
.... Methods and Materials A total of 1440 patients (1449 cases) with early-stage breast cancer receiving breast-conserving therapy were treated with the MammoSite device... 
Radiology | Hematology, Oncology and Palliative Medicine | MammoSite | Partial-breast irradiation | Brachytherapy | Breast cancer | Breast-conserving therapy | Radiation | TOXICITY | INITIAL CLINICAL-EXPERIENCE | CANCER | ONCOLOGY | OUTCOMES | CATHETER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | RADIATION-THERAPY SYSTEM | Breast Neoplasms - surgery | Carcinoma in Situ - chemistry | Carcinoma in Situ - drug therapy | Follow-Up Studies | Humans | Middle Aged | Receptors, Estrogen - analysis | Carcinoma in Situ - radiotherapy | Carcinoma, Ductal, Breast - chemistry | Breast Neoplasms - chemistry | Carcinoma, Ductal, Breast - drug therapy | Carcinoma in Situ - surgery | Aged, 80 and over | Adult | Carcinoma, Ductal, Breast - pathology | Female | Registries | Radiotherapy Dosage | Esthetics | Carcinoma, Ductal, Breast - surgery | Brachytherapy - instrumentation | Carcinoma in Situ - pathology | Brachytherapy - methods | Treatment Outcome | Tumor Burden | Breast Neoplasms - drug therapy | Breast Neoplasms - radiotherapy | Breast Neoplasms - pathology | Carcinoma, Ductal, Breast - radiotherapy | Aged | Neoplasms, Second Primary - pathology | Brachytherapy - adverse effects | Index Medicus | MAMMARY GLANDS | NEOPLASMS | MEDICINE | NUCLEAR MEDICINE | ORGANS | DISEASES | THERAPY | GLANDS | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | BRACHYTHERAPY | EFFICIENCY | BODY | RADIOLOGY
Journal Article
Nature reviews. Clinical oncology, ISSN 1759-4782, 2010, Volume 7, Issue 12, pp. 683 - 692
This Review outlines the understanding and management of triple-negative breast cancer (TNBC... 
EPITHELIAL-MESENCHYMAL TRANSITION | EXPRESSION PATTERNS | MOLECULAR SUBTYPES | POLY(ADP-RIBOSE) POLYMERASE | ONCOLOGY | BASAL-LIKE SUBTYPE | PHASE-II | GENE AMPLIFICATION | ESTROGEN-RECEPTOR STATUS | PROGESTERONE-RECEPTOR | PROGNOSTIC MARKERS | Carcinoma, Ductal, Breast - genetics | Prognosis | Humans | Gene Expression Regulation, Neoplastic | Drug Resistance, Neoplasm | Antineoplastic Agents - therapeutic use | Gene Expression Profiling | Receptors, Estrogen - analysis | Receptors, Progesterone - genetics | Carcinoma, Ductal, Breast - chemistry | Breast Neoplasms - therapy | Carcinoma, Ductal, Breast - classification | Receptors, Progesterone - analysis | Breast Neoplasms - chemistry | Neoplasm Metastasis | Carcinoma, Ductal, Breast - pathology | Female | Antineoplastic Agents - pharmacology | Genes, BRCA1 | Antineoplastic Agents - classification | BRCA1 Protein - deficiency | Neoplasm Proteins - genetics | Breast Neoplasms - classification | Receptors, Estrogen - genetics | Neoplasm Invasiveness | Neoplasm Proteins - biosynthesis | Neoplasm Recurrence, Local | BRCA1 Protein - physiology | Combined Modality Therapy | Carcinoma, Ductal, Breast - therapy | Mitotic Index | Breast Neoplasms - genetics | Case Management | Breast Neoplasms - pathology | Genes, erbB-2 | Receptors, Estrogen - biosynthesis | Neoplasm Proteins - analysis | Receptor, ErbB-2 - analysis | Receptors, Progesterone - biosynthesis | Chemotherapy | BRCA mutations | Breast cancer | Genetic aspects | Diagnosis | Research | Drug therapy | Health aspects | Risk factors | Cancer
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 387, Issue 10021, pp. 857 - 865
Journal Article
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 2009, Volume 106, Issue 9, pp. 3372 - 3377
Epithelial-stromal cell interactions have an important role in breast tumor progression, but the molecular mechanisms underlying these effects are just beginning to be understood... 
Up regulation | Cell growth | Epithelial cells | Stromal cells | Coculture techniques | Fibroblasts | Breast cancer | Heterologous transplantation | Tumors | Cancer | Stroma | Celecoxib | DCIS | Tumor progression | KAPPA-B ACTIVATION | ANGIOGENESIS | celecoxib | MULTIDISCIPLINARY SCIENCES | stroma | PREVENTION | breast cancer | TRANSITION | tumor progression | INHIBITION | CANCER DEVELOPMENT | MICROENVIRONMENT | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | CYCLOOXYGENASE-2 EXPRESSION | Carcinoma, Ductal - pathology | Humans | NF-kappa B - metabolism | Carcinoma, Ductal - drug therapy | Breast Neoplasms - enzymology | Stromal Cells - enzymology | Neoplasm Invasiveness - pathology | Cyclooxygenase 2 Inhibitors - therapeutic use | Female | Disease Models, Animal | Carcinoma, Ductal - blood supply | NF-kappa B - antagonists & inhibitors | Cell Communication | Breast Neoplasms - blood supply | Breast Neoplasms - drug therapy | Disease Progression | Xenograft Model Antitumor Assays | Animals | Signal Transduction - drug effects | Breast Neoplasms - pathology | Mice, Nude | Carcinoma, Ductal - enzymology | Cyclooxygenase 2 - metabolism | Epithelial Cells - enzymology | Cell Line, Tumor | Mice | Breast tumors | Causes of | Carcinoma, Ductal | Development and progression | Chemical properties | Drug therapy | Health aspects | Biological Sciences
Journal Article
Nature medicine, ISSN 1546-170X, 2011, Volume 17, Issue 4, pp. 500 - 503
Journal Article
The lancet oncology, ISSN 1470-2045, 2013, Volume 14, Issue 7, pp. 609 - 618
Journal Article
Journal Article